[Results of a clinical study on a new dermatologic agent].
D000731:Androstanes / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004304:Dosage Forms; D004357:Drug Synergism; D005260:Female; D005461:Fluorine / Q000627:therapeutic use; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D007664:Ketosteroids / Q000627:therapeutic use; D008297:Male; D011278:Pregnanes / Q000627:therapeutic use*; D011379:Prognosis; D012871:Skin Diseases / Q000188:drug therapy*
D000731:Androstanes; D000900:Anti-Bacterial Agents; D004304:Dosage Forms; D006146:Guanidines; D007664:Ketosteroids; D011278:Pregnanes; D005461:Fluorine
Ergebnisse der klinischen Prüfung eines neuen Dermatotherapeutikums.